1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MDM2-p53 in liposarcoma: The need for targeted therapies with novel mechanisms of action
    Review

    Somaiah, N.; Tap, W.
    Cancer Treatment Reviews (2024)

    Fulltext@MSK | Save
  • Early-onset pancreatic neuroendocrine tumors: Clinical presentation, pathology features, and oncological outcomes
    Journal Article

    Pulvirenti, A.; Hauser, H. F.; Fiedler, L. M.; McIntyre, C. A.; Le, T.; Reidy-Lagunes, D. L.; Soares, K. C.; Balachandran, V. P.; Kingham, T. P.; D'Angelica, M. I.; more...
    Annals of Surgery (2024)

    Fulltext@MSK | Save
  • APR-246 increases tumor antigenicity independent of p53
    Journal Article

    Michels, J.; Venkatesh, D.; Liu, C.; Budhu, S.; Zhong, H.; George, M. M.; Thach, D.; Yao, Z. K.; Ouerfelli, O.; Liu, H.; more...
    Life Science Alliance (2024)

    Fulltext@MSK | Save
  • Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation
    Journal Article

    Thor, M.; Fitzgerald, K.; Apte, A.; Hun Oh, J.; Iyer, A.; Odiase, O.; Nadeem, S.; Yorke, E. D.; Chaft, J.; Wu, A. J.; more...
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
    Journal Article

    Hepner, A.; Versluis, J. M.; Wallace, R.; Allayous, C.; Brown, L. J.; Trojaniello, C.; Gerard, C. L.; Jansen, Y. J. L.; Bhave, P.; Neyns, B.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility
    Journal Article

    Pinto, E. M.; Fridman, C.; Figueiredo, B. C.; Salvador, H.; Teixeira, M. R.; Pinto, C.; Pinheiro, M.; Kratz, C. P.; Lavarino, C.; Legal, E. A. M. F.; more...
    Human Genetics and Genomics Advances (2024)

    Fulltext@MSK | Save
  • Cancer modeling by transgene electroporation in adult zebrafish (TEAZ)
    Journal Article

    Montal, E.; Suresh, S.; Ma, Y.; Tagore, M. M.; White, R. M.; Amatruda, J. F.; Houart, C.; Kawakami, K.; Poss, K. D.
    Methods in Molecular Biology (2024)

    Fulltext@MSK | Save
  • Honing in on the hospital-at-home model
    Editorial

    Mullangi, S.; Daly, B.
    Mayo Clinic Proceedings: Digital Health (2023)

    Fulltext@MSK | Save
  • ENGOT-EN20/GOG-3083/XPORT-EC-042 a phase 3, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy for patients with P53 wild-type, advanced or recurrent endometrial carcinoma
    Meeting Abstract

    Vergote, I.; Mirza, M. R.; Coleman, R.; Fidalgo, J. P.; Monk, B.; Valabrega, G.; Slomovitz, B.; Van Gorp, T.; Moore, K.; Sehouli, J.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Phase 1/2 study of galinpepimut-S plus pembrolizumab combination in patients with WT1+platinum-resistant ovarian cancer in 2nd/3rd line of therapy
    Meeting Abstract

    Ocearbhaill, R.; Holmes, J.; Bastos, B.; Fu, S. Q.; Muenzen, R.; Cohen, J.; Cicic, D.; Ali, S.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save